Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
31 participants
INTERVENTIONAL
2010-04-30
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
E-health Intervention for Cancer Survivors 2.0
NCT01348997
Developing and Pre-Testing an eHealth Group Intervention for Young Adult Cancer Survivors
NCT05054569
A Web-Based Tool to Improve Breast Cancer Survivorship
NCT03849573
Feasibility of a Technology-Based Intervention for Depression Referral Uptake in Cancer Survivors
NCT07091968
Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors
NCT07290543
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The internet promises to provide inexpensive access to treatment at any time of the day or night. Unfortunately, the potential for internet delivered services has not been realized. Studies examining treatments that simply provide access to an internet site commonly result in very high dropout after the first site visit, and typically little or no improvement target symptoms. A variety of methods to improve responses to internet interventions have been examined. In general, e-mail support improves adherence and telephone support can improve adherence even more. Another type of support that has only begun to be investigated is the use of social networks to help maintain adherence.
This intervention will combine a variety of outreach methods, including telephone, email and an online social network, to increase adherence and promote the use of the website and the skills it teaches.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Project Onward website + social network
This arm has the website which includes 8 weeks of Internet-based cognitive behavioral therapy combined with discussion and support from a group of up to 8 other cancer survivors.
Project Onward website + social network
The website will include 8 weeks of Internet-based cognitive behavioral therapy combined with discussion and support from a group of up to 8 other cancer survivors.
Project Onward website
This arm has the website which includes 8 weeks of Internet-based cognitive behavioral therapy.
Project Onward website
Access to an interactive website that provides 8 weeks of Internet-based cognitive behavioral therapy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Project Onward website + social network
The website will include 8 weeks of Internet-based cognitive behavioral therapy combined with discussion and support from a group of up to 8 other cancer survivors.
Project Onward website
Access to an interactive website that provides 8 weeks of Internet-based cognitive behavioral therapy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Has completed treatment for cancer and is currently in full remission.
3. ECOG performance Status of \< 3.
4. No history of hospitalization for psychiatric reasons with in the past 5 years.
5. Has a telephone, e-mail account, computer, and broadband access to the Internet.
6. Has familiarity with using the Internet that allows for adequate navigation of website.
7. Is able to speak and read English.
8. Is at least 19 years of age.
9. Is able to give informed consent.
Exclusion Criteria
2. Has visual impairment that would prevent use of the website and completion of assessment materials.
3. Diagnosis of basal or squamous cell skin cancers
3\) Has physical impairments that would limit use of the computer. 4) Meets criteria for dementia by scoring \< 25 on the Telephone Interview for Cognitive Status (TICS).
5\) Is diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, current post-traumatic stress disorder (PTSD), current substance abuse, or other diagnosis for which participation in a clinical trial of an internet intervention may be either inappropriate or dangerous, or has been hospitalized for psychiatric reasons within the past 5 years. Patients with substance abuse diagnoses who have been abstinent for 3 months will be admitted if otherwise eligible.
6\) Is currently receiving individual psychotherapy or planning to receive psychotherapy during the 8-week treatment phase of the study.
7\) Is planning to be out of town or unavailable for treatment for 2 weeks or more during the scheduled treatment time.
8\) Exhibits severe suicidality, including ideation, plan, and intent. 9) Has initiated treatment with an antidepressant in past 10 days. Once patients have been on a stable dose for 10 days and do not have an appointment with a physician or psychiatrist to change this dose, the patient will be eligible based on this criterion.
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Mohr
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David C. Mohr, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern University
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00026896
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.